FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News

Cesarean for Early Preterm Births Tied to Maternal Risks

Cesarean delivery for very early preterm births is linked to higher rates of severe maternal complications than vaginal delivery for such cases.

New Blood Tests Fall Short of Replacing Food Challenge

Component testing cuts false positives and cellular assays promise more accuracy, but logistics keep them out of routine practice.

Nurse-Led Care Improves Asthma Control in Children

Nurse-led asthma care improves asthma control in children aged 6-12 years in primary care in a study.

Dupilumab May Ease Ear Inflammation in Severe CRSwNP

For patients with severe CRSwNP and concomitant eosinophilic otitis media, dupilumab treatment may provide meaningful benefits over a 12-month period.

Drug-Induced Lupus: Predicting Systemic Disease Risk

Certain antibodies and systemic symptoms at diagnosis are more frequent in patients with drug-induced subacute cutaneous lupus who develop systemic lupus erythematosus.

Immunotherapy in NSCLC: How Much Is Enough?

Immunotherapy has moved from a last-resort option in NSCLC to a fixture at nearly every stage of the disease, but there's a gap between what the trials tested and how it's actually being used.

Todays Updates

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

FDA Expands Label of Oral HIV Drug to Newborns

Dolutegravir is already approved as combination therapy in adults and older children

Postpartum Psychosis: Who Is Most at Risk?

Disease has a continuum of severity, perinatal psychiatrist explains

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Todays Updates

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

FDA Expands Label of Oral HIV Drug to Newborns

Dolutegravir is already approved as combination therapy in adults and older children

Postpartum Psychosis: Who Is Most at Risk?

Disease has a continuum of severity, perinatal psychiatrist explains

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Latest News

Cesarean delivery for very early preterm births is linked to higher rates of severe maternal complications than vaginal delivery for such cases.

Component testing cuts false positives and cellular assays promise more accuracy, but logistics keep them out of routine practice.

Nurse-led asthma care improves asthma control in children aged 6-12 years in primary care in a study.

For patients with severe CRSwNP and concomitant eosinophilic otitis media, dupilumab treatment may provide meaningful benefits over a 12-month period.

Certain antibodies and systemic symptoms at diagnosis are more frequent in patients with drug-induced subacute cutaneous lupus who develop systemic lupus erythematosus.

Immunotherapy has moved from a last-resort option in NSCLC to a fixture at nearly every stage of the disease, but there's a gap between what the trials tested and how it's actually being used.

News All Time

Host-Directed Therapies and Phages in Lung Care

Host-directed and phage therapies are emerging as alternatives to antibiotics in managing lung infections in a worsening antimicrobial resistance crisis.

As-Needed Allergic Rhinitis Meds Comparable to Daily Use

Patients with allergic rhinitis who use medication as needed can achieve symptom control and treatment satisfaction comparable to those achieved by patients who use them daily.

S1P Modulators: 5 Agents, One Safety Playbook

Five S1P modulators now span neurology and GI. Bruce Cree, MD, PhD, and others weigh in on why selectivity differences are no longer academic.

Mild Brain Injury Frequently Missed in the ED

Only 21% of adults with closed head injury have mTBI diagnosed or clinically suspected in the ED, despite 41% meeting diagnostic criteria, with missed diagnoses most common among middle-aged adults.

A Rare Hearing Implant Bypasses Damaged Nerves

When cochlear implants failed, doctors turned to a brainstem auditory implant to restore sound awareness in a patient with profound deafness.

D10 Matches D50 for Hypoglycemia, Shows Lower Rebound Risk

A lower-concentration dextrose solution matches the standard treatment for hypoglycemia in the emergency department but carries a lower risk for rebound hypoglycemia.

Two-Midnight Rule: Key Strategies for Observation Patients

The Two-Midnight Rule has created important clinical and operational strategies for hospitals.

Pediatric Atopic Dermatitis: Biologic Revolution Continues

The pediatric atopic dermatitis treatment landscape expands as new biologics emerge, and researchers ask whether earlier intervention can change the course of disease.

Pediatric Asthma Flares Rise After School Resumes

Asthma flare-ups spike in the weeks after school starts, when viral exposure, allergens, and missed maintenance treatment can converge in children.

AAD Issues Guidelines on Treatment-Refractory Adult Eczema

Experts suggest a more ‘whole person’ differential diagnosis when adults do not respond to atopic dermatitis treatment.

Clinicians Should Be on Alert for Measles in Adults

Data suggests that infected adults are being hospitalized as often, or more than, children younger than 5 years.

SLE Incidence Appears to Peak Later in Men Than in Women

A meta-analysis finds that systemic lupus erythematosus is most often diagnosed among women in their 30s and men in their 60s, with notable differences seen across races and ethnicities.

Mast Cell Activation Syndrome: Patients Look for Answers

For patients with unexplained multisystem symptoms, getting answers can mean navigating competing criteria and conflicting information.

Enhancing Quality of Life for Terminally Ill Veterans

Honoring individualized preferences for end-of-life interventions for veterans is a priority for families and caregivers; this study explores various nonpharmacologic interventions.

US FDA Extends Review Of Exelixis' Cancer Drug

The U.S. Food and Drug Administration has extended the review of Exelixis' experimental colorectal cancer drug combination ⁠by three months, the company said in a filing on...

CDC Issues Alert on Rabies Exposure, Appropriate Treatment

The agency expresses concern that a rise in use of postexposure prophylaxis could indicate a lack of understanding of when to administer the therapy.

Recommended News For You

Taking vitamin D daily decreased cancer mortality, according to a study.

fresh E. Coli Outbreak: ECMO Redefining Death and Bringing Universal Blood One Step Nearer.

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.

Scientists pioneer noninvasive 3D imaging to enhance skin cancer management

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

Recommended Articles For You

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer  

Patient-Derived Response Maps for Therapy Selection: A Scientific Review 

Spatial Pharmacology Within the Tumor Microenvironment: Precision in Oncologic Therapeutics 

Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pancreatic cancer RNA vaccine shows durable T cell immunity

2.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

3.

Exercise can counter detrimental effects of cancer treatment, review suggests

4.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

5.

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

1.

Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation 

2.

Targeting Oncology: Expanding Combinatorial Strategies by 2025

3.

Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications

4.

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?

5.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

3.

Understanding Blood Clotting Disorders

4.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

5.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot